Literature DB >> 8398580

Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration.

P T Pollak1, A D Sharma, S G Carruthers.   

Abstract

Serum creatinine and drug concentrations were measured at 0, 1, 2, 3, 6, 9 and 12 months in 30 consecutive patients started on amiodarone. In 28 of these patients with no obvious cause for altered renal function, mean serum creatinine increased to 11% above baseline (P < 0.005). Rising creatinine concentrations correlated with amiodarone concentrations (y = 93.9 + 8.6x, r = 0.51, P < 0.0001). When assessing elevation of serum creatinine in a patient receiving amiodarone, physicians should be aware that it may be related to this drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398580      PMCID: PMC1364575          DOI: 10.1111/j.1365-2125.1993.tb04207.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Serum creatinine increase associated with amiodarone therapy.

Authors:  M B Jacobs
Journal:  N Y State J Med       Date:  1987-06

2.  Quality of the ideal antiarrhythmic drug.

Authors:  L S Dreifus; S Ogawa
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

3.  Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.

Authors:  P T Pollak; A D Sharma; S G Carruthers
Journal:  Am J Cardiol       Date:  1990-05-15       Impact factor: 2.778

4.  Measured versus estimated creatinine clearance in the elderly as an index of renal function.

Authors:  T Gral; M Young
Journal:  J Am Geriatr Soc       Date:  1980-11       Impact factor: 5.562

5.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

6.  Cardiac function in patients on chronic amiodarone therapy.

Authors:  K A Ellenbogen; W G O'Callaghan; P G Colavita; M S Smith; L D German
Journal:  Am Heart J       Date:  1985-08       Impact factor: 4.749

7.  Simplified liquid-chromatographic assay of amiodarone and desethylamiodarone after solid-phase extraction.

Authors:  P T Pollak; S G Carruthers; D J Freeman
Journal:  Clin Chem       Date:  1986-05       Impact factor: 8.327

  7 in total
  6 in total

1.  Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.

Authors:  Robert D Shamburek; Rebecca Bakker-Arkema; Bruce J Auerbach; Brian R Krause; Reynold Homan; Marcelo J Amar; Lita A Freeman; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2015-12-23       Impact factor: 4.766

2.  High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study.

Authors:  Andreas J Mayr; Martin W Dünser; Nicole Ritsch; Werner Pajk; Barbara Friesenecker; Hans Knotzer; Hanno Ulmer; Volker Wenzel; Walter R Hasibeder
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

3.  Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.

Authors:  Aditya J Ullal; Claire T Than; Jun Fan; Susan Schmitt; Alexander C Perino; Daniel W Kaiser; Paul A Heidenreich; Susan M Frayne; Ciaran S Phibbs; Mintu P Turakhia
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

4.  Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis.

Authors:  James F Doyle; Kwok M Ho
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

5.  Influence of concomitant medication on plasma concentration of amiodarone in patients with atrial fibrillation - a pilot study.

Authors:  Maria Adriana Neag; Dana Maria Muntean; Alexandra Nacu; Adrian Catinean; Anca Farcas; Stefan Vesa; Corina Bocsan; Laurian Vlase; Anca Dana Buzoianu
Journal:  Med Pharm Rep       Date:  2019-04-25

6.  Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.

Authors:  Eve-Irene Lepist; Xuexiang Zhang; Jia Hao; Jane Huang; Alan Kosaka; Gabriel Birkus; Bernard P Murray; Roy Bannister; Tomas Cihlar; Yong Huang; Adrian S Ray
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.